Adding Shock Wave Therapy to Kinesio Taping Improves Carpal Tunnel Syndrome in Physical Therapist Females.

March 26, 2024 updated by: Mina Magdy Wahba, Cairo University

Adding Shock Wave Therapy to Kinesio Taping Improves Carpal Tunnel Syndrome in Physical Therapist Females. A Randomized Controlled Trial.

PURPOSE: To investigate the effect of adding Shock wave therapy to kinesio taping on relieving carpal tunnel syndrome symptoms in physical therapist females.

BACKGROUND: shockwave therapy is a popular non-invasive therapeutic modality in the medical field for the treatment of numerous musculoskeletal disorders. Shockwaves can generate interstitial and extracellular responses, producing many beneficial effects such as: pain relief, vascularization, protein biosynthesis, cell proliferation, neuro and chondroprotection, and destruction of calcium deposits in musculoskeletal structures. shockwave combined with conventional physiotherapy is an effective noninvasive treatment for mild-to-moderate carpal tunnel syndrome that produces greater and longer-lasting results than conventional physiotherapy alone HYPOTHESES: Adding Shock wave therapy to kinesio taping has positive effects on carpal tunnel syndrome in physical therapist females.

RESEARCH QUESTION: Does adding Shock wave therapy to kinesio taping has positive effects on carpal tunnel syndrome in physical therapist females?

Study Overview

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients aged between 20 and 40 years
  • diagnosed as having mild and moderate carpal tunnel syndrome through clinical parameters and nerve conduction studies (NCSs),

Exclusion Criteria:

- Having any systemic diseases such as renal failure, peptic ulcer, diabetes mellitus, hypothyroidism, coagulopathy, inflammatory rheumatic disease, having a cardiac pacemaker, cervical radiculopathy, polyneuropathy or brachial plexopathy, systemic corticosteroid use, fracture or trauma history in the forearm and wrist pregnancy and lactation, having received a carpal tunnel syndrome surgery, thoracic outlet syndrome or severe carpal tunnel syndrome.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Shockwave
One group received shock wave therapy with the conventional physical therapy program including kinesio taping
Shockwave therapy
Kinesio taping application
conventional physical therapy
Active Comparator: conventional
conventional physical therapy program including kinesio taping without shock wave therapy
Kinesio taping application
conventional physical therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Visual Analog Scale
Time Frame: 1 and 12 week
It is a self reported outcome which is a 10 cm line with zero at one end indicating no pain and 10 at the other end indicating maximum pain. Patient will be asked to mark the current pain on the scale and the distance from the starting point (0) will be measured
1 and 12 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numbness Visual Analog Scale
Time Frame: 1 and 12 week
It is self reported outcome, which is a 10 cm line with zero at one end indicating no numbness and 10 at the other end indicating maximum numbness.Patient will be asked to mark the current numbness on the scale, and the distance from the starting point (0) will be measured
1 and 12 week
Boston Carpal Tunnel Questionnaire
Time Frame: 1 and 12 week
a Questionnaire widely used for assessing function and/or symptoms in patients with carpal tunnel syndrome. It consists of two separate scales: the Symptom Severity Scale (SSS), which consists of 11 questions and the Functional Status Scale (FSS), which consists of 8 items and requires respondents to score the difficulty of each item on a five-point scale. A final score is calculated for each scale (the sum of the individual scores divided by the number of items) and ranges from 1 to 5, with a higher score indicating a more severe handicap.
1 and 12 week
handgrip strength
Time Frame: 1 and 12 week
hand grip strength will be measured by a hand held dynamometer Participants will be instructed to grip the dynamometer as strongly as they possibly can, using their affected hand. Three measurements will be taken and the highest value will be used in the analysis
1 and 12 week
electrodiagnostic study for median nerve
Time Frame: 1 and 12 week
Sensory distal latency and motor distal latency of the median nerve will be measured by electromyography device according to standard protocol ( sensory distal latency stimulated at wrist and recorded 14cm at middle finger) and motor distal latency was stimulated at wrist and recorded from abductor pollicis brevis muscle.
1 and 12 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Omnya samy Abdallah Ghoneim, PhD, Department of Physical Therapy for Pediatrics and Pediatric Surgery, Faculty of Physical Therapy, Badr University in Cairo, Egypt.
  • Principal Investigator: Mina Magdy Wahba, PhD, Department of Physical Therapy for Musculoskeletal Disorders and Surgery, Faculty of Physical Therapy, Badr University in Cairo, Cairo, Egypt.
  • Study Chair: Fatma Said Zidan Hamed, PhD, Department of Physical therapy for Neuromuscular Disorders & its Surgery, Faculty of Physical Therapy, Badr University in Cairo, Egypt
  • Study Director: Hanaa Samir Mohamed Abd el fatah, PhD, Faculty of Physical therapy, Modern University for Technology and Information, Egypt.
  • Study Chair: Doha Hamed Moustafa Al-Afify, PhD, Basic Sciences Department, Faculty of Physical Therapy, Badr University in Cairo, Egypt

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 20, 2024

Primary Completion (Estimated)

June 1, 2024

Study Completion (Estimated)

July 1, 2024

Study Registration Dates

First Submitted

December 11, 2023

First Submitted That Met QC Criteria

January 17, 2024

First Posted (Actual)

January 19, 2024

Study Record Updates

Last Update Posted (Actual)

March 27, 2024

Last Update Submitted That Met QC Criteria

March 26, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physiopathology

Clinical Trials on Shockwave

3
Subscribe